426 related articles for article (PubMed ID: 25740988)
1. Single-Chain Soluble BG505.SOSIP gp140 Trimers as Structural and Antigenic Mimics of Mature Closed HIV-1 Env.
Georgiev IS; Joyce MG; Yang Y; Sastry M; Zhang B; Baxa U; Chen RE; Druz A; Lees CR; Narpala S; Schön A; Van Galen J; Chuang GY; Gorman J; Harned A; Pancera M; Stewart-Jones GB; Cheng C; Freire E; McDermott AB; Mascola JR; Kwong PD
J Virol; 2015 May; 89(10):5318-29. PubMed ID: 25740988
[TBL] [Abstract][Full Text] [Related]
2. Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits.
Yasmeen A; Ringe R; Derking R; Cupo A; Julien JP; Burton DR; Ward AB; Wilson IA; Sanders RW; Moore JP; Klasse PJ
Retrovirology; 2014 May; 11():41. PubMed ID: 24884783
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Uncleaved and Mature Human Immunodeficiency Virus Membrane Envelope Glycoprotein Trimers.
Castillo-Menendez LR; Witt K; Espy N; Princiotto A; Madani N; Pacheco B; Finzi A; Sodroski J
J Virol; 2018 Jun; 92(12):. PubMed ID: 29618643
[TBL] [Abstract][Full Text] [Related]
4. A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.
Sanders RW; Derking R; Cupo A; Julien JP; Yasmeen A; de Val N; Kim HJ; Blattner C; de la Peña AT; Korzun J; Golabek M; de Los Reyes K; Ketas TJ; van Gils MJ; King CR; Wilson IA; Ward AB; Klasse PJ; Moore JP
PLoS Pathog; 2013 Sep; 9(9):e1003618. PubMed ID: 24068931
[TBL] [Abstract][Full Text] [Related]
5. Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity.
Chuang GY; Geng H; Pancera M; Xu K; Cheng C; Acharya P; Chambers M; Druz A; Tsybovsky Y; Wanninger TG; Yang Y; Doria-Rose NA; Georgiev IS; Gorman J; Joyce MG; O'Dell S; Zhou T; McDermott AB; Mascola JR; Kwong PD
J Virol; 2017 May; 91(10):. PubMed ID: 28275193
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody.
Cheng C; Pancera M; Bossert A; Schmidt SD; Chen RE; Chen X; Druz A; Narpala S; Doria-Rose NA; McDermott AB; Kwong PD; Mascola JR
J Virol; 2015 Dec; 90(6):2740-55. PubMed ID: 26719262
[TBL] [Abstract][Full Text] [Related]
7. Conformational States of a Soluble, Uncleaved HIV-1 Envelope Trimer.
Liu Y; Pan J; Cai Y; Grigorieff N; Harrison SC; Chen B
J Virol; 2017 May; 91(10):. PubMed ID: 28250125
[TBL] [Abstract][Full Text] [Related]
8. A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene.
Pugach P; Ozorowski G; Cupo A; Ringe R; Yasmeen A; de Val N; Derking R; Kim HJ; Korzun J; Golabek M; de Los Reyes K; Ketas TJ; Julien JP; Burton DR; Wilson IA; Sanders RW; Klasse PJ; Ward AB; Moore JP
J Virol; 2015 Mar; 89(6):3380-95. PubMed ID: 25589637
[TBL] [Abstract][Full Text] [Related]
9. SOS and IP Modifications Predominantly Affect the Yield but Not Other Properties of SOSIP.664 HIV-1 Env Glycoprotein Trimers.
Ringe RP; Colin P; Torres JL; Yasmeen A; Lee WH; Cupo A; Ward AB; Klasse PJ; Moore JP
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619555
[TBL] [Abstract][Full Text] [Related]
10. Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures.
Harris A; Borgnia MJ; Shi D; Bartesaghi A; He H; Pejchal R; Kang YK; Depetris R; Marozsan AJ; Sanders RW; Klasse PJ; Milne JL; Wilson IA; Olson WC; Moore JP; Subramaniam S
Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11440-5. PubMed ID: 21709254
[TBL] [Abstract][Full Text] [Related]
11. Influences on the Design and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers.
Ringe RP; Yasmeen A; Ozorowski G; Go EP; Pritchard LK; Guttman M; Ketas TA; Cottrell CA; Wilson IA; Sanders RW; Cupo A; Crispin M; Lee KK; Desaire H; Ward AB; Klasse PJ; Moore JP
J Virol; 2015 Dec; 89(23):12189-210. PubMed ID: 26311893
[TBL] [Abstract][Full Text] [Related]
12. Stable 293 T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studies.
Chung NP; Matthews K; Kim HJ; Ketas TJ; Golabek M; de Los Reyes K; Korzun J; Yasmeen A; Sanders RW; Klasse PJ; Wilson IA; Ward AB; Marozsan AJ; Moore JP; Cupo A
Retrovirology; 2014 Apr; 11():33. PubMed ID: 24767177
[TBL] [Abstract][Full Text] [Related]
13. Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation.
Ringe RP; Sanders RW; Yasmeen A; Kim HJ; Lee JH; Cupo A; Korzun J; Derking R; van Montfort T; Julien JP; Wilson IA; Klasse PJ; Ward AB; Moore JP
Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18256-61. PubMed ID: 24145402
[TBL] [Abstract][Full Text] [Related]
14. Well-ordered trimeric HIV-1 subtype B and C soluble spike mimetics generated by negative selection display native-like properties.
Guenaga J; de Val N; Tran K; Feng Y; Satchwell K; Ward AB; Wyatt RT
PLoS Pathog; 2015 Jan; 11(1):e1004570. PubMed ID: 25569572
[TBL] [Abstract][Full Text] [Related]
15. SOSIP Changes Affect Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Conformation and CD4 Engagement.
Alsahafi N; Anand SP; Castillo-Menendez L; Verly MM; Medjahed H; Prévost J; Herschhorn A; Richard J; Schön A; Melillo B; Freire E; Smith AB; Sodroski J; Finzi A
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021898
[TBL] [Abstract][Full Text] [Related]
16. Specific amino acids in the N-terminus of the gp41 ectodomain contribute to the stabilization of a soluble, cleaved gp140 envelope glycoprotein from human immunodeficiency virus type 1.
Dey AK; David KB; Klasse PJ; Moore JP
Virology; 2007 Mar; 360(1):199-208. PubMed ID: 17092531
[TBL] [Abstract][Full Text] [Related]
17. Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.
Sanders RW; Vesanen M; Schuelke N; Master A; Schiffner L; Kalyanaraman R; Paluch M; Berkhout B; Maddon PJ; Olson WC; Lu M; Moore JP
J Virol; 2002 Sep; 76(17):8875-89. PubMed ID: 12163607
[TBL] [Abstract][Full Text] [Related]
18. A New Approach to Produce HIV-1 Envelope Trimers: BOTH CLEAVAGE AND PROPER GLYCOSYLATION ARE ESSENTIAL TO GENERATE AUTHENTIC TRIMERS.
AlSalmi W; Mahalingam M; Ananthaswamy N; Hamlin C; Flores D; Gao G; Rao VB
J Biol Chem; 2015 Aug; 290(32):19780-95. PubMed ID: 26088135
[TBL] [Abstract][Full Text] [Related]
19. Structure-Guided Redesign Increases the Propensity of HIV Env To Generate Highly Stable Soluble Trimers.
Guenaga J; Dubrovskaya V; de Val N; Sharma SK; Carrette B; Ward AB; Wyatt RT
J Virol; 2015 Dec; 90(6):2806-17. PubMed ID: 26719252
[TBL] [Abstract][Full Text] [Related]
20. Development of a RPLC-UV method for monitoring uncleaved HIV-1 envelope glycoprotein.
Schneck NA; Vinitsky AL; Ivleva VB; Wang X; Gowetski DB; Lei QP
Anal Methods; 2021 May; 13(19):2183-2188. PubMed ID: 33954330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
